This research explores brain stimulation as a safe, low-cost alternative to medication for children with neurological and mental health conditions. Despite promising results across disorders, only a small fraction of studies involve children. The work aims to expand evidence and access, improving global treatment options, especially for low-income populations.

This research examines how keeping secrets in romantic relationships harms well-being. It introduces “fear of discovery,” the anxiety that secrets will be revealed unintentionally. Findings show this fear increases obsessive thinking and reduces relationship and life satisfaction, offering new insight into why secrecy negatively affects mental health.

This research explores how the hippocampus and prefrontal cortex communicate to support memory for sequences of events. By understanding how these brain regions track past, present, and future, the work aims to shed light on cognitive impairments seen in disorders such as Alzheimer’s disease and depression.

This research explores how early-life stress alters reward motivation differently in males and females. By identifying sex-specific brain circuits and wiring patterns shaped by early stress, it reveals why individuals respond differently to reward and highlights the need for personalized approaches to mental health treatment.

Drawing on personal experience with depression and anxiety, this researcher studies synaptic adhesion molecules—key proteins that shape how neural connections form and adapt. By understanding how these molecules change across development, the work aims to uncover molecular mechanisms behind neuropsychiatric disorders and inform future treatments or prevention strategies.

This study introduces a “brain stress test” for depression, combining targeted brain stimulation with neuroimaging. Depressed individuals show exaggerated brain responses, which increase with repeated episodes. The test may serve as an early warning signal, helping clinicians identify relapse risk and intervene before depression returns.

Mental health disorders disrupt neural connections in the brain, yet most treatments only manage symptoms. This research explores psychedelic-inspired drugs that restore lost brain connections without hallucinogenic effects, using automated imaging tools to identify compounds that rebuild neural structure and offer lasting recovery.

This research proposes that psychotherapy works by reshaping cognitive maps in the brain, much like navigation. In depression, these maps become narrow and repetitive. By analyzing therapy language and concept networks, this work aims to make therapy more precise—helping clinicians visualize mental “stuck points” and guide patients toward healthier paths.

Psychiatric symptoms often precede neurodegenerative diseases, but the biological link remains unclear. This research examines the FMR1 gene using postmortem brain tissue to uncover shared molecular mechanisms, aiming to predict neurodegeneration earlier, improve treatment strategies, and reframe psychiatric symptoms as potential early warning signs.

This research explores how chronic stress reshapes the brain through genetic mechanisms. By studying the stress-regulating gene MeCP2 in mice, the work shows how early-life stress can lock the brain into a heightened anxiety state, revealing biological pathways that may inform future treatments for stress-related mental health disorders.